Healthcare provider profile · identity verified

David Robert Deberny, M.D.

Internal Medicine · ORCHARD PARK, NY · NPI 1861456642

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	694	207
Levothyroxine Sodium	Levothyroxine Sodium	508	154
Amlodipine Besylate	Amlodipine Besylate	442	134
Atorvastatin Calcium	Atorvastatin Calcium	293	92
Losartan Potassium	Losartan Potassium	259	75
Metoprolol Succinate	Metoprolol Succinate	249	71
Omeprazole	Omeprazole	200	65
Benazepril Hcl	Benazepril Hcl	190	53
Famotidine	Famotidine	184	62
Metformin Hcl	Metformin Hcl	183	65
Escitalopram Oxalate	Escitalopram Oxalate	172	55
Lisinopril	Lisinopril	172	56
Gabapentin	Gabapentin	140	30
Mounjaro	Tirzepatide	137	22
Fluticasone Propionate	Fluticasone Propionate	130	51
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	124	30
Prednisone	Prednisone	123	71
Allopurinol	Allopurinol	119	38
Jardiance	Empagliflozin	116	33
Clonazepam	Clonazepam	112	31
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	111	35
Synthroid	Levothyroxine Sodium	107	30
Hydrochlorothiazide	Hydrochlorothiazide	104	38
Pantoprazole Sodium	Pantoprazole Sodium	102	33
Albuterol Sulfate Hfa	Albuterol Sulfate	101	53
Simvastatin	Simvastatin	101	30
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	88	20
Duloxetine Hcl	Duloxetine Hcl	82	21
Furosemide	Furosemide	82	30
Irbesartan	Irbesartan	80	22
Metoprolol Tartrate	Metoprolol Tartrate	71	20
Eliquis	Apixaban	69	18
Zolpidem Tartrate	Zolpidem Tartrate	68	16
Metformin Hcl Er	Metformin Hcl	67	22
Lorazepam	Lorazepam	63	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	60	45
Tamsulosin Hcl	Tamsulosin Hcl	55	19
Alprazolam	Alprazolam	54	27
Bupropion Xl	Bupropion Hcl	53	14
Potassium Chloride	Potassium Chloride	53	21
Clopidogrel	Clopidogrel Bisulfate	52	15
Spironolactone	Spironolactone	50	16
Pravastatin Sodium	Pravastatin Sodium	48	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	45	13
Cefdinir	Cefdinir	45	35
Ezetimibe	Ezetimibe	45	16
Sertraline Hcl	Sertraline Hcl	44	14
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Ramipril	Ramipril	41	15
Trazodone Hcl	Trazodone Hcl	41	13
Pioglitazone Hcl	Pioglitazone Hcl	40	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	17
Mirtazapine	Mirtazapine	38	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	13
Celecoxib	Celecoxib	36	16
Donepezil Hcl	Donepezil Hcl	36	suppressed
Azithromycin	Azithromycin	33	26
Buspirone Hcl	Buspirone Hcl	33	suppressed
Carvedilol	Carvedilol	33	11
Raloxifene Hcl	Raloxifene Hcl	33	suppressed
Alendronate Sodium	Alendronate Sodium	32	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	32	suppressed
Diazepam	Diazepam	31	11
Montelukast Sodium	Montelukast Sodium	31	13
Valsartan	Valsartan	31	suppressed
Amoxicillin	Amoxicillin	30	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Clonidine Hcl	Clonidine Hcl	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Ibuprofen	Ibuprofen	27	14
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Enalapril Maleate	Enalapril Maleate	26	suppressed
Glipizide Er	Glipizide	26	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	26	26
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	19
Sulindac	Sulindac	26	12
Atenolol	Atenolol	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Folic Acid	Folic Acid	23	suppressed
Tramadol Hcl	Tramadol Hcl	23	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	17
Valacyclovir	Valacyclovir Hcl	21	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	11
Tiotropium Bromide	Tiotropium Bromide	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	18
Prolia	Denosumab	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Clindamycin Hcl	Clindamycin Hcl	17	12
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Glipizide	Glipizide	16	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	16	suppressed
Single Use Swab	Alcohol Antiseptic Pads	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Baclofen	Baclofen	14	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	12
Ketoconazole	Ketoconazole	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Ozempic	Semaglutide	13	suppressed
Repatha Syringe	Evolocumab	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Cephalexin	Cephalexin	12	12
Epinephrine	Epinephrine	12	11
Icosapent Ethyl	Icosapent Ethyl	12	suppressed
Invokana	Canagliflozin	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Ramelteon	Ramelteon	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Colchicine	Colchicine	11	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Nitroglycerin Patch	Nitroglycerin	11	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error